The Global Female Technology (FemTech) market is anticipated to surge at an astronomical rate on account escalating adoption for telehealth service, rise in various menstrual diseases, and rapid digitalization. The growing concern toward women’s personal health and hygiene, boost in private and public funding to support and promote the fem-tech start-ups due to growing end users, and rising awareness about this emerging field in healthcare, along with easy accessibility of reimbursement for women health services, and availability of features such as tampon subscriptions through mobile apps have been major factors which encouraged the growth of FemTech market in the forecast period. In 2019, around USD 563 million was invested in various global projects in the field of FemTech.
According to MarkNtel Advisors’ research report titled “Global Female Technology (FemTech) Market Analysis, 2020”, the Global Female Technology market is anticipated to grow at a CAGR of around 11.4% during 2020-25. Based on Application, Pelvic and Uterine segment is expected to attain highest CAGR in the forthcoming period. Pelvic and Uterine segment is categorized into Pelvic Wellness and Menstrual Health. The growing concerns amongst women about menstrual health is surging due to a significant rise in Polycystic Ovary Disease (PCOD) and Polycystic Ovary Syndrome (PCOS) incidences. PCOS is a hormonal disease generally occurring among the women who are of reproductive age. 1 in every 4 women suffers from PCOS with half of cases going undiagnosed.
“Global Female Technology (FemTech) Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Female Technology providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.
Asia-Pacific Acquired Significant Market Share
Asia-Pacific is estimated to attain highest CAGR by 2025 on an account of extensive funding so as to promote FemTech start-ups which are focusing on digital health in women. Japan, China, and Singapore markets are expected to grow at a high rate in the near future. The growth is attributed to growing number of chronic and communicable diseases, presence of viable healthcare infrastructure, and launch of various female hygiene products by the FemTech players for women in urban and rural areas which are expected to strongly contribute to the market growth of the FemTech market in the forecast period as stated in MarkNtel Advisors’ research report “Global Female Technology (FemTech) Market Analysis, 2020”.
According to MarkNtel Advisors, the key players with a considerable market share in the Global Female Technology market are AVA AG, Aytu BioScience, Inc., Biowink GmbH, Bloomlife, Inc., Flo Health, Inc., Glow, Inc., NaturalCycles Nordic AB, Ovia Health, Conceivable Inc., Celmatic, Inc. etc.
Key questions answered in the study: